Voya Investment Management LLC Fate Therapeutics Inc Transaction History
Voya Investment Management LLC
- $80 Billion
- Q3 2024
A detailed history of Voya Investment Management LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Voya Investment Management LLC holds 33,434 shares of FATE stock, worth $42,461. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,434
Previous 33,254
0.54%
Holding current value
$42,461
Previous $109,000
7.34%
% of portfolio
0.0%
Previous 0.0%
Shares
34 transactions
Others Institutions Holding FATE
# of Institutions
169Shares Held
116MCall Options Held
53.7KPut Options Held
9K-
Redmile Group, LLC San Francisco, CA13.2MShares$16.7 Million3.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$13.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$12.8 Million0.0% of portfolio
-
Boxer Capital, LLC San Diego, CA4.96MShares$6.3 Million0.92% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.84MShares$6.15 Million0.29% of portfolio
About FATE THERAPEUTICS INC
- Ticker FATE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,000,304
- Market Cap $123M
- Description
- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...